Top News

Illumina Buys Verinata Health




San Diego-based life sciences equipment firm Illumina said over the weekend that it is in an agreement to acquire Verinata Health, a provider of non-invasive testing for fetal chromosomal abnormalities. Illumnina said it would pay $350M plus up to $100M in milestone payments for Verinata. Verinata's tests are used for prenatal testing. Illumina was advised by Bank of America Merrill Lynch and Covington & Burling LLP in the deal. Verinata was venture backed by Alloy Ventures, Mohr Davidow Ventures, and Sutter Hill Ventures.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel